Regency Capital Management’s CVS Health CVS Stock Holding History

Regency Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$236K	–	47
2024 Q2	$236K	Hold	4,000	–	–	0.15%	44
2024 Q1	$319K	Sell	4,000 -500	-11%	-$38.2K	0.2%	44
2023 Q4	$355K	Hold	4,500	–	–	0.24%	43
2023 Q3	$314K	Hold	4,500	–	–	0.27%	38
2023 Q2	$311K	Buy	+4,500	New	+$320K	0.27%	34
2022 Q3	–	Sell	-1,000	Closed	-$93K	–	51
2022 Q2	$93K	Sell	1,000 -211	-17%	-$20.6K	0.1%	46
2022 Q1	$123K	Hold	1,211	–	–	0.09%	61
2021 Q4	$125K	Sell	1,211 -1,020	-46%	-$94.3K	0.08%	66
2021 Q3	$189K	Buy	2,231 +1,020	+84%	+$85.4K	0.13%	61
2021 Q2	$101K	Sell	1,211 -39,901	-97%	-$3.27M	0.08%	74
2021 Q1	$3.09M	Buy	+41,112	New	+$2.99M	3.25%	4

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Regency Capital Management's CVS Position: Q3 2024 in Review

Regency Capital Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,000 shares — an estimated $236K sold.

Regency Capital Management first reported a position in CVS in Q1 2021 and held it in 11 quarters. The position peaked at $3.09M in Q1 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Regency Capital Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Regency Capital Management sold 4,000 CVS Health shares in Q3 2024, an estimated $236K.
Regency Capital Management first reported a position in CVS Health in Q1 2021 and held it in 11 quarters.
Regency Capital Management's CVS Health position peaked at $3.09M in Q1 2021.
1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Regency Capital Management's 13F filing for Q3 2024, filed 4 Oct 2024.